Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.
2.

Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

Clin Ther. 2005 Sep;27(9):1383-91.

PMID:
16291411
3.

Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase.

Sarafidis PA, Lasaridis AN, Nilsson PM, Pagkalos EM, Hitoglou-Makedou AD, Pliakos CI, Kazakos KA, Yovos JG, Zebekakis PE, Tziolas IM, Tourkantonis AN.

J Hypertens. 2004 Sep;22(9):1769-77.

PMID:
15311106
4.

Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin?

Wulffelé MG, Kooy A, Lehert P, Bets D, Donker AJ, Stehouwer CD.

Diabet Med. 2005 Jul;22(7):907-13.

PMID:
15975107
5.

Ambulatory blood pressure measurement in type-II diabetic patients with autonomic neuropathy.

Migdalis IN, Zachariadis D, Hatzigakis SM, Kourti A, Kalantzis L.

J Med. 1996;27(5-6):333-40.

PMID:
9151201
7.

Insulin treatment of elderly type 2 diabetic patients: effects on retinopathy.

Tovi J, Ingemansson SO, Engfeldt P.

Diabetes Metab. 1998 Nov;24(5):442-7.

10.

Metabolic control in insulin-treated type 2-diabetic patients aged over 80 years and without participation in a structured diabetic teaching program.

Sedlak M, Raml A, Schmekal B, Grafinger P, Biesenbach G.

Wien Med Wochenschr. 2005 Jan;155(1-2):26-9.

PMID:
15773741
12.

Effect of insulin therapy on blood pressure in NIDDM patients with secondary failure.

Randeree HA, Omar MA, Motala AA, Seedat MA.

Diabetes Care. 1992 Oct;15(10):1258-63.

PMID:
1425085
13.

The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS.

Diabetes Care. 1998 May;21(5):701-5.

PMID:
9589227
14.

Combination of insulin and metformin in the treatment of type 2 diabetes.

Wulffelé MG, Kooy A, Lehert P, Bets D, Ogterop JC, Borger van der Burg B, Donker AJ, Stehouwer CD.

Diabetes Care. 2002 Dec;25(12):2133-40.

PMID:
12453950
16.
17.

NIDDM: a rapid progressive disease. Results from a long-term, randomised, comparative study of insulin or sulphonylurea treatment.

Birkeland KI, Rishaug U, Hanssen KF, Vaaler S.

Diabetologia. 1996 Dec;39(12):1629-33.

PMID:
8960854
18.

'Glucose control-related' and 'non-glucose control-related' effects of insulin on weight gain in newly insulin-treated type 2 diabetic patients.

Sallé A, Ryan M, Guilloteau G, Bouhanick B, Berrut G, Ritz P.

Br J Nutr. 2005 Dec;94(6):931-7.

PMID:
16351770
19.

Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension.

Uehara MH, Kohlmann NE, Zanella MT, Ferreira SR.

Diabetes Obes Metab. 2001 Oct;3(5):319-25.

PMID:
11703421
20.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
Items per page

Supplemental Content

Write to the Help Desk